Sign in
4

Changes in Ownership

Traws Pharma, Inc. Filed Acc 0002018274-25-000003

Options or other derivatives

  • Chief Medical Officer acquired 32,406 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Redfield Robert Chief Medical Officer 2025-10-12 Grant or award · Stock Option (right to purchase) +32,406 32,406 D: show line 1 in the form
Loading xslF345X05/form4-10162025_121036.xml…